#flozins — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #flozins, aggregated by home.social.
-
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY.
It was obvious then (and it is now) that they don't understand how UACR works as a biomarker -
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY.
It was obvious then (and it is now) that they don't understand how UACR works as a biomarker -
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY.
It was obvious then (and it is now) that they don't understand how UACR works as a biomarker -
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY.
It was obvious then (and it is now) that they don't understand how UACR works as a biomarker -
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY.
It was obvious then (and it is now) that they don't understand how UACR works as a biomarker -
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY. It was obvious then (and it is now) that they don't understand how UACR works as a biomarker
-
It seems the usual #EBM suspects are making snarky comments about #CONFIDENCE similar to their comments about #flozins #sglt2i in the years leading up to CREDENCE/DAPA-CKD/EMPA-KIDNEY. It was obvious then (and it is now) that they don't understand how UACR works as a biomarker
-
Nephrologis' take on the effect and impact of SGLT-2 inhibitors and GLP-1RA #diabetes https://www.slideshare.net/slideshow/nephrologist-s-take-on-the-effect-and-impact-of-sglt-2-inhibitors-and-glp-1-ras-on-kidney-disease-in-people-with-diabetes/271231000 via @SlideShare #DiabetesCare #CKD #flozins #GLP1RA
-
Nephrologis' take on the effect and impact of SGLT-2 inhibitors and GLP-1RA #diabetes https://www.slideshare.net/slideshow/nephrologist-s-take-on-the-effect-and-impact-of-sglt-2-inhibitors-and-glp-1-ras-on-kidney-disease-in-people-with-diabetes/271231000 via @SlideShare #DiabetesCare #CKD #flozins #GLP1RA
-
Nephrologis' take on the effect and impact of SGLT-2 inhibitors and GLP-1RA #diabetes https://www.slideshare.net/slideshow/nephrologist-s-take-on-the-effect-and-impact-of-sglt-2-inhibitors-and-glp-1-ras-on-kidney-disease-in-people-with-diabetes/271231000 via @SlideShare #DiabetesCare #CKD #flozins #GLP1RA
-
Nephrologis' take on the effect and impact of SGLT-2 inhibitors and GLP-1RA #diabetes https://www.slideshare.net/slideshow/nephrologist-s-take-on-the-effect-and-impact-of-sglt-2-inhibitors-and-glp-1-ras-on-kidney-disease-in-people-with-diabetes/271231000 via @SlideShare #DiabetesCare #CKD #flozins #GLP1RA
-
Spokane doctor's breakthrough #kidney disease treatment (that would be an aldosterone synthase inhibitor) shows promising results with #flozins / #SGLT2i
https://www.kxly.com/news/spokane-doctors-breakthrough-kidney-disease-treatment-shows-promising-results/article_d6991e6a-a12a-11ee-967a-1b03c9ea2b60.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via
See release by #Boehringer https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease -
Spokane doctor's breakthrough #kidney disease treatment (that would be an aldosterone synthase inhibitor) shows promising results with #flozins / #SGLT2i
https://www.kxly.com/news/spokane-doctors-breakthrough-kidney-disease-treatment-shows-promising-results/article_d6991e6a-a12a-11ee-967a-1b03c9ea2b60.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via
See release by #Boehringer https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease -
Spokane doctor's breakthrough #kidney disease treatment (that would be an aldosterone synthase inhibitor) shows promising results with #flozins / #SGLT2i
https://www.kxly.com/news/spokane-doctors-breakthrough-kidney-disease-treatment-shows-promising-results/article_d6991e6a-a12a-11ee-967a-1b03c9ea2b60.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via
See release by #Boehringer https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease -
Spokane doctor's breakthrough #kidney disease treatment (that would be an aldosterone synthase inhibitor) shows promising results with #flozins / #SGLT2i
https://www.kxly.com/news/spokane-doctors-breakthrough-kidney-disease-treatment-shows-promising-results/article_d6991e6a-a12a-11ee-967a-1b03c9ea2b60.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via
See release by #Boehringer https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease -
Spokane doctor's breakthrough #kidney disease treatment (that would be an aldosterone synthase inhibitor) shows promising results with #flozins / #SGLT2i
https://www.kxly.com/news/spokane-doctors-breakthrough-kidney-disease-treatment-shows-promising-results/article_d6991e6a-a12a-11ee-967a-1b03c9ea2b60.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via
See release by #Boehringer https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease -
Should you hesitate to start #Flozins higher when sugars too high? Here’s that idea debunked in a propensity score matched analysis in JAMA IM
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2800884
Efficacy maintained and AEs consistent across HgbA1c strata (and all favouring Flozins except genital infxn)
Any comments @mike_johansen @ChristosArgyrop @Bneuen ?
-
The next edition of #NephTrials on master trial protocols, with a focus on #BasketTrials using the #RENALLIFECYCLES example http://www.nephjc.com/news/master-trials in #Flozins
With a great #VisualAbstract from Denisse Arellano from the ISN social media team
-
The next edition of #NephTrials on master trial protocols, with a focus on #BasketTrials using the #RENALLIFECYCLES example http://www.nephjc.com/news/master-trials in #Flozins
With a great #VisualAbstract from Denisse Arellano from the ISN social media team
-
The next edition of #NephTrials on master trial protocols, with a focus on #BasketTrials using the #RENALLIFECYCLES example http://www.nephjc.com/news/master-trials in #Flozins
With a great #VisualAbstract from Denisse Arellano from the ISN social media team
-
The next edition of #NephTrials on master trial protocols, with a focus on #BasketTrials using the #RENALLIFECYCLES example http://www.nephjc.com/news/master-trials in #Flozins
With a great #VisualAbstract from Denisse Arellano from the ISN social media team
-
The next edition of #NephTrials on master trial protocols, with a focus on #BasketTrials using the #RENALLIFECYCLES example http://www.nephjc.com/news/master-trials in #Flozins
With a great #VisualAbstract from Denisse Arellano from the ISN social media team
-
Sick day rules and #Flozins
Detailed contrarian review and good discussion of #SGLT2i use during hospitalization https://pubmed.ncbi.nlm.nih.gov/35801339/ (gated)
Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing
@ChristosArgyrop & @mike_johansen for thoughts?
See their algorithm: -
Sick day rules and #Flozins
Detailed contrarian review and good discussion of #SGLT2i use during hospitalization https://pubmed.ncbi.nlm.nih.gov/35801339/ (gated)
Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing
@ChristosArgyrop & @mike_johansen for thoughts?
See their algorithm: -
Sick day rules and #Flozins
Detailed contrarian review and good discussion of #SGLT2i use during hospitalization https://pubmed.ncbi.nlm.nih.gov/35801339/ (gated)
Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing
@ChristosArgyrop & @mike_johansen for thoughts?
See their algorithm: -
Sick day rules and #Flozins
Detailed contrarian review and good discussion of #SGLT2i use during hospitalization https://pubmed.ncbi.nlm.nih.gov/35801339/ (gated)
Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing
@ChristosArgyrop & @mike_johansen for thoughts?
See their algorithm: -
Sick day rules and #Flozins
Detailed contrarian review and good discussion of #SGLT2i use during hospitalization https://pubmed.ncbi.nlm.nih.gov/35801339/ (gated)
Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing
@ChristosArgyrop & @mike_johansen for thoughts?
See their algorithm: -
@hswapnil @mike_johansen This is cool! We are working on medication specific guidelines to harmonize prescriptions of #Flozins, #GLP1ra, #nsMRA etc across #primarycare, #cardiology, #endocrinology and #nephrology, which has been a fun project. I think at our institution, nephrology prescribed most aggressively, but that is probably the effect of having Amy Mottl in our division.
-
@EvanZeitler @mike_johansen we made this in Ontario https://www.ontariorenalnetwork.ca/en/kidney-care-resources/clinical-tools/primary-care-tools/kidneywise/toolkit
(We = Scott Brimble, #Nephrologist Allan Grill #familymedicine & team)
- need to add #Flozins etc -
@load_dependent @LaurieTomlinson @jordy_bc @hswapnil
Maybe the rule is: stop #flozins when fasting. Any info on 12-18h fasts as in Ramadan or intermittent fasting?